Fracture of self-expanding nitinol stents stressed in vitro under simulated intravascular conditions

Journal of Vascular Surgery

Volumn 48, Issue 2, 2008, Pages 435-440

  Nikanorov, Alexander ^a   Smouse, H Bob ^b   Osman, Karim ^a   Bialas, Michael ^a   Shrivastava, Sanjay ^a   Schwartz, Lewis B ^a  

^a ABBOTT VASCULAR   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITINOL; PHOSPHATE BUFFERED SALINE; SILICONE;

ARTICLE; CADAVER; COMMERCIAL PHENOMENA; COMPRESSION; CONTROLLED STUDY; HIP; HUMAN; IN VITRO STUDY; KNEE FUNCTION; LIMB MOVEMENT; MECHANICAL STRESS; MECHANICS; PARAMETER; POPLITEAL ARTERY; PRIORITY JOURNAL; RADIOGRAPHY; SIMULATION; STENT; SUPERFICIAL FEMORAL ARTERY;

ALLOYS; BIOMECHANICS; CADAVER; COMPRESSIVE STRENGTH; FEMALE; FEMORAL ARTERY; HUMANS; MALE; POPLITEAL ARTERY; PROSTHESIS FAILURE; SENSITIVITY AND SPECIFICITY; STENTS; STRESS, MECHANICAL;

EID: 47349088904     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.02.029     Document Type: Article

References (31)

1. Schlager O., Petra D., Schila S., Jasmin A., Wolfgang M., Erich M., et al. Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 12 (2005) 676-684
2. Duda S.H., Bosiers M., Lammer J., Scheinert D., Zeller T., Oliva V., et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 13 (2006) 701-710
3. Pentecost M.J., Criqui M.H., Dorros G., Goldstone J., Johnston K.W., Martin E.C., et al. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels: a statement for health professionals from a special writing group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association. J Vasc Interv Radiol 14 (2003) S495-S515
4. Costanza M.J., Queral L.A., Lilly M.P., and Finn W.R. Hemodynamic outcome of endovascular therapy for TransAtlantic Inter Society Consensus type B femoropopliteal arterial occlusive lesions. J Vasc Surg 39 (2004) 343-350
5. BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 (2005) 1925-1934
6. Gray B.H., Sullivan T.M., Childs M.B., Young J.R., and Olin J.W. High incidence of restenosis/reocclusion of intravascular stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 25 (1997) 74-83
7. Schillinger M., Sabeti S., Loewe C., Petra D., Jasmin A., Wolfgang M., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
8. Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary. A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease). J Am Coll Cardiol (2006) 1239-1312
9. Surowiec S., Davies M., Eberly S., Rhodes J., Illig K., Shortell C., et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 41 (2005) 269-278
10. Van der Zaag E.S., Legemate D.A., Prins M.H., Reekers J.A., and Jacobs M.J. Angioplasty or bypass for superficial femoral artery disease?. A randomised controlled trial. Eur J Vasc Endovasc Surg 28 (2004) 132-137
11. Mureebe L., and McKinsey J.F. Infrainguinal arterial intervention: is there a role for an atherectomy device?. Vascular 14 (2006) 313-318
12. Lugmayr H.F., Holzer H., Kastner M., Riedelsberger H., and Auterith A. Treatment of complex atherosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a mid-term follow-up. Radiology 222 (2002) 37-43
13. Mewissen M.W. Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radiol 7 (2004) 2-5
14. Schillinger M., Sabeti S., Dick P., Amighi J., Mlekusch W., Schlager O., et al. Sustained benefit at two years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115 (2007) 2745-2749
15. Smouse H.B., Nikanorov A., and LaFlash D. Biomechanical forces in the femoropopliteal arterial segment. Endovasc Today (2005) 60-66
16. Dubé H., Clifford A.G., Barry C.M., Schwarten D.E., and Schwartz L.B. Comparison of the vascular responses to balloon-expandable stenting in the coronary and peripheral circulations: Long-term results in an animal model using the TriMaxx stent. J Vasc Surg 45 (2007) 821-827
17. Barth K.H., Virmani R., Froelich J., Takeda T., Lossef S.V., Newsome J., et al. Paired comparison of vascular wall reactions to Palmaz stents, Strecker tantalum stents, and Wallstents in canine iliac and femoral arteries. Circulation 93 (1996) 2161-2169
18. Garrett Jr. H.E. A human cadaveric circulation model. J Vasc Surg 33 (2001) 1128-1130
19. Goswami A. A new gait parameterization technique by means of cyclogram moments: application to human slope walking. Gait Posture 8 (1998) 15-36
20. Serruys P.W., Kutryk M.J.B., and Ong A.T.L. Coronary artery stents. N Engl J Med 354 (2006) 483-495
21. Duda S.H., Pusich B., Richter G., Landwehr P., Oliva V.L., Tielbeek A., et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-months results. Circulation 106 (2002) 1505-1509
22. Duda S.H., Bosiers M., Lammer J., Scheinert D., Zeller T., Tielbeek A., et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II Trial. J Vasc Interv Radiol 16 (2005) 331-338
23. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., and Fowkes F.G.R. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45 suppl S (2007) S5A-S67A
24. Laird J., Jaff M.R., Biamino G., McNamara T., Scheinert D., Zetterlund P., et al. Cryoplasty for the treatment of femoropopliteal arterial disease: Results of a prospective, multicenter registry. J Vasc Interv Radiol 16 (2005) 1067-1073
25. White C.J., and Gray W.A. Endovascular therapies for peripheral arterial disease: an evidence-based review. Circulation 116 (2007) 2203-2215
26. Tepe G., Schmehl J., Heller S., Wiesinger B., Claussen C.D., and Duda S.H. Superficial femoral artery: current treatment options. Eur Radiol 16 (2006) 1316-1322
27. Diehm N., Silvestro A., Dai-Do D., Greiner R., Triller J., Mahler F., et al. Endovascular brachytherapy after femoropopliteal balloon angioplasty fails to show robust clinical benefit over time. J Endovasc Ther 12 (2005) 723-730
28. Allie D.E., Hebert C.J., and Walker C.M. Nitinol stent fractures in the SFA. Endovasc Today (2004) Jul/Aug
29. Scheinert D., Scheinert S., Sax J., Piorkowski C., Bräunlich S., Ulrich M., et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45 (2005) 312-315
30. Iida O., Nanto S., Uematsu M., Morozumi T., Kotani J.I., Awata M., et al. Effect of exercise on frequency of stent fracture in the superficial femoral artery. Am J Cardiol 98 (2006) 272-274
31. Nikanorov A., Pike K., Boylan J., and Rapoza R. Is there a specificity in the construction of a stent for the superficial femoral artery?. In: Chafke N., Durand B., and Kretz J.G. (Eds). New technologies in vascular biomaterials: fundamentals about stents II (2007), Europrot, Strasbourg, France 117-123